Results 171 to 180 of about 14,143,268 (384)

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Online 'penny auction' sites: regulation needed [PDF]

open access: yes, 2008
Online 'penny auction' sites allow bidders to win expensive items at a price that appears unbelievably cheap, however users are charged by the site for each bid that they place.
Griffiths, MD
core  

Nickel−Iron Dithiolato Hydrides Relevant to the [NiFe]-Hydrogenase Active Site

open access: green, 2009
Bryan E. Barton   +3 more
openalex   +2 more sources

Productive wetlands restored for carbon sequestration quickly become net CO2 sinks with site-level factors driving uptake variability

open access: gold, 2021
Alex Valach   +9 more
openalex   +1 more source

Zooming‐in – Visualization of active site heterogeneity in high entropy alloy electrocatalysts using scanning electrochemical cell microscopy [PDF]

open access: gold, 2021
Emmanuel Batsa Tetteh   +10 more
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

open access: yesMolecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz   +12 more
wiley   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Managing contaminated sites [PDF]

open access: yes
This audit assessed how well the risks associated with contaminated sites in New South Wales are being managed. Executive summary Effective management of contaminated land makes an important contribution to the government’s goal to ‘Protect our natural

core  

Home - About - Disclaimer - Privacy